Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Huang, C.-T. Articles by Li, S.-Y. Search for Related Content PubMed PubMed Citation Articles by Huang, C.-T. Articles by Li, S.-Y.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2008, p. 1126-1128, Vol. 46, No. 3
0095-1137/08/$08.00+0     doi:10.1128/JCM.02278-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Genotyping of Chlamydia trachomatis by Microsphere Suspension Array

Chung-Ter Huang,¹ Wing-Wai Wong,² Lan-Hui Li,² Chien-Chou Chiang,² Bor-Dong Chen,¹ and Shu-Ying Li^1*

Mycotic Diseases Laboratory, Research and Diagnostic Center, Centers for Disease Control, Taipei, Taiwan,¹ Department of Contagious Disease Prevention, Taipei City Hospital, Taipei, Taiwan²

Received 26 November 2007/ Accepted 20 December 2007

Top ABSTRACT TEXT REFERENCES

 
The identification of Chlamydia trachomatis genotypes is important for both the study of molecular epidemiology and infection control. We have developed a microsphere suspension array assay that can identify C. trachomatis genotypes rapidly and accurately and also discriminate among multiple genotypes in one clinical specimen.

Top ABSTRACT TEXT REFERENCES

 
The Chlamydia trachomatis infection is the most prevalent sexually transmitted bacterial disease. It is estimated that 89 million cases occur annually worldwide (3). Because 50% of infected men and 80% of infected women are asymptomatic, the actual number of reported cases represents only a fraction of the infected population (3). Currently, 19 human serovars have been recognized by using polyclonal and monoclonal antibodies against the major outer membrane protein (2, 4, 9, 10, 12). However, the serological typing method usually requires the culturing of clinical isolates and large pools of monoclonal antibodies, which make it difficult to apply in a clinical laboratory (13). Recently, different molecular methods targeting VS2 or VS1-VS2 of the omp1 gene have been reported for the genotyping of C. trachomatis (6, 7, 11, 13). In this study, we develop a microsphere suspension array (MSA) method to identify C. trachomatis genotypes. This method allows one to conduct multiple biological reactions simultaneously in a single reaction vessel, like other array-based methods (7, 11, 13). The MSA assay exhibits higher multiplexing capability (i.e., simultaneous detection of up to 100 different targets) and is a fast, simple, and accurate method for identifying genotypes and yielding quantitative results.

The DNA sequences of the omp1 gene of eight known C. trachomatis genotypes (Ba, D, E, F, G, H, J, and K) were obtained from the GenBank database. The specific probes targeting the VS2 region of C. trachomatis were designed by analyzing these eight sequences or were modified from previous reports (Table 1) (7, 11, 13). All probes were checked for specificity against all the sequences obtained from the GenBank database using BioEdit version 7.0 software. Probes with a 5'-end amino C-12 modification (Purigo Biotech, Taipei, Taiwan) were coupled to carboxylated beads (Bio-Rad Laboratories, Inc., Hercules, CA).

View this table: [in this window] [in a new window]

TABLE 1. Probes used for multiplex genotyping of C. trachomatis VS1-VS2 PCR products

To evaluate the reproducibility, sensitivity, and specificity of the MSA method, plasmids containing the omp1 VS1-VS2 fragment of the Ba, D, E, F, G, H, J, and K genotypes from clinical specimens were constructed. The process of nested PCR amplification has been described in a previous report, except for the 5'-end modification of the inner pair of primers (MOMP87/C214) with biotin (Purigo Biotech) (5).

To determine the specificity and efficiency of these probes, 17 µl biotinylated PCR products amplified from plasmid of different genotypes were mixed with 33 µl of 1.5x tetramethylammonium chloride (TMAC) solution (4.5 M TMAC, 0.15% Sarkosyl, 75 mM Tris-HCl at pH 8.0, and 6 mM EDTA at pH 8.0) (Sigma, St. Louis, MO) and a mixture of 5,000 probe-coupled beads from each set in a 1.5-ml microcentrifuge tube. The mixture was denatured at 95°C for 5 min and incubated at 45°C for 35 min. Then, the beads were resuspended in 75 µl of streptavidin-R-phycoerythrin diluted 1:250 in 1x TMAC (3 M TMAC, 0.1% Sarkosyl, 50 mM Tris-HCl at pH 8.0, and 4 mM EDTA at pH 8.0) and incubated for 10 min. The beads were analyzed for internal bead color and R-phycoerythrin reporter fluorescence on the Bio-Plex 200 analyzer (Bio-Rad Laboratories, Inc., Hercules, CA).

The minimum ratio is the lowest recorded positive signal value divided by the highest recorded negative signal value. A minimum ratio value greater than 2 is used as the threshold for defining positive events (8). The positive signals of eight genotype-specific probes ranged from 68 to 977, and the minimum ratios ranged from 2.4 to 19.4, as shown in Table 1. Probe sequences were adopted from a previous report of a reverse line blot assay. Probes Ba, D, E, H, and K could be applied directly in this system (11, 13). For genotypes F and G, antisense probes were used to improve the signal intensity. In addition, a one-nucleotide mismatch was designed for probe J to increase its specificity for genotype J and to prevent cross-hybridization.

Tenfold serial dilutions of eight type-specific plasmid DNAs (Ba, D, E, F, G, H, J, and K) ranging from 4 ng to 4 fg were used to determine the sensitivity. The lowest limit of detection for all eight genotypes was 40 fg (data not shown).

To test the reproducibility of the MSA method, three replicates were tested for a set of the eight different plasmid-derived PCR products. All repeated tests generated the same results, suggesting that the reproducibility of the suspension array technology assay was 100%.

Because of the limitations of gene sequencing and restriction fragment length polymorphism, multiple infections with different C. trachomatis genotypes were difficult to identify. Molecular cloning of clinical specimens could increase the rate of discovering multiple infections (1). However, it was laborious to screen and sequence different clones. To determine whether genotype-specific C. trachomatis probes could accurately discriminate among multiple genotypes in one clinical specimen, plasmid DNA of a genotype (40 pg) was mixed with another genotype DNA (4 pg) to simulate dual infection (10:1) with multiple genotypes in a clinical specimen and then submitted for PCR amplification and MSA array to identify the distinct genotypes in the clinical specimen. However, for some combinations, the mixed ratio had to be changed from 10:1 to 1:1 or 2:1 in order to improve the discriminatory power. Although the fluorescence signals of different genotypes were influenced partly by multiple DNA competitions, the minimum ratios were all more than 2.0 and thus indicated that different genotypes were discriminated correctly (Table 2). Therefore, compared to gene sequencing or restriction fragment length polymorphism, the MSA assay is economical, time saving, and able to identify multiple infections in one sample.

View this table: [in this window] [in a new window]

TABLE 2. Detection (minimum ratios) of different genotypes mixed 10:1 in individual specimens

One hundred twenty specimens were used to test the applicability of the MSA assay to the genotyping of C. trachomatis from clinical specimens. The specimens were collected by the STD clinic of the Taipei City STD Control Center, and diagnosis of C. trachomatis was conducted using the Cobas test (Roche Diagnostic Systems, Inc., Branchburg, NJ). Among the 120 samples tested with the Cobas assay, 63 (28 urine and 35 endocervical swabs) were positive and 57 (28 urine and 29 endocervical swabs) were negative for C. trachomatis. DNAs were extracted from the clinical specimens using the QIAamp viral RNA minikit (Qiagen, Hilden, Germany). The results from the MSA assay were in agreement with those from the Cobas assay. The genotype results for 61 positive specimens were in accordance with the results obtained by the sequencing method. Two cases previously identified as genotypes D and K by DNA sequencing were found to be dual infections of D/K and K/E, respectively, by the MSA assay (Table 3). This confirmed the capability of the MSA system to identify multiple infections in one clinical specimen.

View this table: [in this window] [in a new window]

TABLE 3. Multiplex genotyping of C. trachomatis VS1-VS2 PCR products from clinical specimens

In conclusion, the MSA assay described in this study provides a simple, fast, and high-throughput tool for C. trachomatis genotyping. The results of C. trachomatis genotyping may facilitate the surveillance of strain circulation, the identification of a high-risk population within the sexual network, and the tracing and medical management of sexual partners. Therefore, this assay could be used for C. trachomatis genotyping in large epidemiological studies.

 
This work was supported by grants DOH97-DC-2008 and DOH96-DC-1017 from the Center for Disease Control, Department of Health, Taiwan.

 
* Corresponding author. Mailing address: Mycotic Diseases Laboratory, Research and Diagnostic Center, Centers for Disease Control, No. 161, Kun-Yang Street, Taipei, Taiwan. Phone: 886-2-26531388. Fax: 886-2-26513572. E-mail: syl{at}cdc.gov.tw

Published ahead of print on 3 January 2008.

Top ABSTRACT TEXT REFERENCES

 

1
1. Anderson, M., J. Handley, L. Hopwood, S. Murant, M. Stower, and N. J. Maitland. 1997. Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing. J. Med. Virol. 52:8-13.[CrossRef][Medline]
2
2. Eckert, L. O., R. J. Suchland, S. E. Hawes, and W. E. Stamm. 2000. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J. Infect. Dis. 182:540-544.[CrossRef][Medline]
3
3. Gaydos, C. A., M. Theodore, N. Dalesio, B. J. Wood, and T. C. Quinn. 2004. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J. Clin. Microbiol. 42:3041-3045.[Abstract/Free Full Text]
4
4. Grayston, J. T., and S. Wang. 1975. New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132:87-105.[Medline]
5
5. Hsu, M. C., P. Y. Tsai, K. T. Chen, L. H. Li, C. C. Chiang, J. J. Tsai, L. Y. Ke, H. Y. Chen, and S. Y. Li. 2006. Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J. Med. Microbiol. 55:301-308.[Abstract/Free Full Text]
6
6. Jalal, H., H. Stephen, S. Alexander, C. Carne, and C. Sonnex. 2007. Development of real-time PCR assays for genotyping of Chlamydia trachomatis. J. Clin. Microbiol. 45:2649-2653.[Abstract/Free Full Text]
7
7. Molano, M., C. J. L. M. Meijer, S. A. Morre, R. Pol, and A. J. C. van den Brule. 2004. Combination of PCR targeting the VD2 of omp1 and reverse line blot analysis for typing of urogenital Chlamydia trachomatis serovars in cervical scrape specimens. J. Clin. Microbiol. 42:2935-2939.[Abstract/Free Full Text]
8
8. Page, B. T., and C. P. Kurtzman. 2005. Rapid identification of Candida species and other clinically important yeast species by flow cytometry. J. Clin. Microbiol. 43:4507-4514.[Abstract/Free Full Text]
9
9. Suchland, R. J., and W. E. Stamm. 1991. Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis. J. Clin. Microbiol. 29:1333-1338.[Abstract/Free Full Text]
10
10. Wang, S. P., C. C. Kuo, R. C. Barnes, R. S. Stephens, and J. T. Grayston. 1985. Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J. Infect. Dis. 152:791-800.[Medline]
11
11. Xiong, L., F. Kong, H. Zhou, and G. L. Gilbert. 2006. Use of PCR and reverse line blot hybridization assay for rapid simultaneous detection and serovar identification of Chlamydia trachomatis. J. Clin. Microbiol. 44:1413-1418.[Abstract/Free Full Text]
12
12. Yuan, Y., Y. X. Zhang, N. G. Watkins, and H. D. Caldwell. 1989. Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect. Immun. 57:1040-1049.[Abstract/Free Full Text]
13
13. Zheng, H. P., L. F. Jiang, D. Y. Fang, Y. H. Xue, Y. A. Wu, J. M. Huang, and Z. Y. Ou. 2007. Application of an oligonucleotide array assay for rapid detecting and genotyping of Chlamydia trachomatis from urogenital specimens. Diagn. Microbiol. Infect. Dis. 57:1-6.[CrossRef][Medline]

---

Journal of Clinical Microbiology, March 2008, p. 1126-1128, Vol. 46, No. 3
0095-1137/08/$08.00+0     doi:10.1128/JCM.02278-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Huang, C.-T. Articles by Li, S.-Y. Search for Related Content PubMed PubMed Citation Articles by Huang, C.-T. Articles by Li, S.-Y.